Wooseok Han

762 total citations
14 papers, 385 citations indexed

About

Wooseok Han is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Wooseok Han has authored 14 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Wooseok Han's work include Synthesis and biological activity (5 papers), Cancer Mechanisms and Therapy (3 papers) and Quinazolinone synthesis and applications (3 papers). Wooseok Han is often cited by papers focused on Synthesis and biological activity (5 papers), Cancer Mechanisms and Therapy (3 papers) and Quinazolinone synthesis and applications (3 papers). Wooseok Han collaborates with scholars based in United States, Switzerland and Canada. Wooseok Han's co-authors include Mark Lautens, Mark E. Scott, Mika Lindvall, Matthew T. Burger, Cornelia Bellamacina, Gordana Atallah, Pablo D. García, Gisele Nishiguchi, Paul Feucht and Liana M. Klivansky and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Wooseok Han

14 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wooseok Han United States 10 306 91 61 41 18 14 385
Nada Aljaeed Egypt 10 210 0.7× 178 2.0× 25 0.4× 48 1.2× 26 1.4× 10 347
Ohoud J. Alotaibi Egypt 9 235 0.8× 197 2.2× 29 0.5× 44 1.1× 20 1.1× 9 371
Eman A. Abd El‐Meguid Egypt 11 307 1.0× 135 1.5× 25 0.4× 48 1.2× 40 2.2× 14 391
Perrine Six France 9 261 0.9× 215 2.4× 27 0.4× 68 1.7× 14 0.8× 15 383
Charles D. Spencer United States 7 174 0.6× 116 1.3× 11 0.2× 70 1.7× 14 0.8× 7 296
Eman M. H. Abbas Egypt 16 605 2.0× 161 1.8× 24 0.4× 37 0.9× 48 2.7× 45 683
Ola H. Rizk Egypt 10 312 1.0× 82 0.9× 24 0.4× 33 0.8× 20 1.1× 13 373
Peng-Cheng Diao China 9 332 1.1× 118 1.3× 28 0.5× 40 1.0× 14 0.8× 10 385
Janet D. Culshaw United Kingdom 4 171 0.6× 103 1.1× 22 0.4× 64 1.6× 38 2.1× 6 280
Sanadelaslam S. A. El‐Hddad Egypt 9 255 0.8× 180 2.0× 38 0.6× 65 1.6× 18 1.0× 13 347

Countries citing papers authored by Wooseok Han

Since Specialization
Citations

This map shows the geographic impact of Wooseok Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wooseok Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wooseok Han more than expected).

Fields of papers citing papers by Wooseok Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wooseok Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wooseok Han. The network helps show where Wooseok Han may publish in the future.

Co-authorship network of co-authors of Wooseok Han

This figure shows the co-authorship network connecting the top 25 collaborators of Wooseok Han. A scholar is included among the top collaborators of Wooseok Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wooseok Han. Wooseok Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Park, Jaewoo, Myung Jun Kim, Sang Young Oh, et al.. (2025). High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader. Experimental Hematology and Oncology. 14(1). 89–89. 2 indexed citations
2.
Kim, Eunjung, et al.. (2024). Abstract 3313: Discovery of a potent, selective, and orally available small molecule for disruption of the SOS1-RAS interaction. Cancer Research. 84(6_Supplement). 3313–3313. 1 indexed citations
3.
Han, Wooseok, Yu Ding, Zheng Chen, et al.. (2020). Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases. Journal of Medicinal Chemistry. 63(23). 14885–14904. 4 indexed citations
4.
Ma, Xiaolei, Ramadevi Prathapam, Charles Wartchow, et al.. (2019). Structural and Biological Basis of Small Molecule Inhibition of Escherichia coli LpxD Acyltransferase Essential for Lipopolysaccharide Biosynthesis. ACS Infectious Diseases. 6(6). 1480–1489. 18 indexed citations
5.
Han, Wooseok, Daniel L. Menezes, Yongjin Xu, et al.. (2016). Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 26(3). 742–746. 20 indexed citations
6.
Nishiguchi, Gisele, Matthew T. Burger, Wooseok Han, et al.. (2016). Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold. Bioorganic & Medicinal Chemistry Letters. 26(9). 2328–2332. 13 indexed citations
7.
Han, Wooseok, Yu Ding, Yongjin Xu, et al.. (2016). Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design. Journal of Medicinal Chemistry. 59(7). 3034–3045. 15 indexed citations
8.
Bagdanoff, Jeffrey T., et al.. (2015). Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase. Bioorganic & Medicinal Chemistry Letters. 25(18). 3788–3792. 21 indexed citations
9.
Bagdanoff, Jeffrey T., Wooseok Han, Daniel Poon, et al.. (2015). Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase. Bioorganic & Medicinal Chemistry Letters. 25(17). 3626–3629. 14 indexed citations
10.
Pecchi, Sabina, Zhi‐Jie Ni, Wooseok Han, et al.. (2013). Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3K. Bioorganic & Medicinal Chemistry Letters. 23(16). 4652–4656. 6 indexed citations
11.
Nishiguchi, Gisele, Gordana Atallah, Cornelia Bellamacina, et al.. (2011). Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases. Bioorganic & Medicinal Chemistry Letters. 21(21). 6366–6369. 47 indexed citations
12.
Scott, Mark E., Wooseok Han, & Mark Lautens. (2004). A Highly Diastereoselective MgI2-Mediated Ring Expansion of Methylenecyclopropanes. Organic Letters. 6(19). 3309–3312. 46 indexed citations
13.
Lautens, Mark, et al.. (2003). MgI2-Mediated Ring Expansions of Secondary Methylenecyclopropyl Amides. Journal of the American Chemical Society. 125(14). 4028–4029. 70 indexed citations
14.
Lautens, Mark & Wooseok Han. (2002). Divergent Selectivity in MgI2-Mediated Ring Expansions of Methylenecyclopropyl Amides and Imides. Journal of the American Chemical Society. 124(22). 6312–6316. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026